Covenant Clinical Research pa is categorized under Medical Research in San Antonio, TX .
Covenant Clinical Research pa was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Ronald Garcia, Owner at the company’s single location by writing to 2829 Babcock Road # 540, San Antonio, Texas TX 78229 or by phoning (210) 614-3030. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Covenant Clinical Research pa |
| Contact Person: | Ronald Garcia, Owner |
| Address: | 2829 Babcock Road # 540, San Antonio, Texas 78229 |
| Phone Number: | (210) 614-3030 |
| Website Address: | covenantclinicalresearch.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417115 |
| Share This Business: |
Covenant Clinical Research pa was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Ronald Garcia, Owner for inquiries that concern Covenant Clinical Research pa by calling the company number (210) 614-3030, as your correspondence is most welcome. Additionally, the physical location of the single location of Covenant Clinical Research pa can be found at the coordinates 29.513919,-98.591869 as well as the street address 2829 Babcock Road # 540 in San Antonio, Texas 78229.
For its online presence, you may visit Covenant Clinical Research pa’s website at covenantclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.